Related references
Note: Only part of the references are listed.Spectroscopic characterization and crystal structures of two cathinone derivatives: N-ethyl-2-amino-1-phenylpropan-1-one (ethcathinone) hydrochloride and N-ethyl-2-amino-1-(4-chlorophenyl)propan-1-one (4-CEC) hydrochloride
Piotr Kus et al.
FORENSIC TOXICOLOGY (2017)
Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC
Janez Klavz et al.
FORENSIC SCIENCE INTERNATIONAL (2016)
The potential utility of some legal highs in CNS disorders
Colin Davidson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Making a medicine out of MDMA
Ben Sessa et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Cathinone Neurotoxicity (The 3Ms)
Steven B. Karch
CURRENT NEUROPHARMACOLOGY (2015)
Synthetic Cathinones: A New Public Health Problem
Laurent Karila et al.
CURRENT NEUROPHARMACOLOGY (2015)
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial
Herman Soto-Molina et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
European rating of drug harms
Jan van Amsterdam et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The European Drug Emergencies Network (Euro-DEN)
D. M. Wood et al.
CLINICAL TOXICOLOGY (2014)
Emerging drugs in Europe
Esther Papaseit et al.
CURRENT OPINION IN PSYCHIATRY (2014)
New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
Claudio Vidal Gine et al.
DRUG TESTING AND ANALYSIS (2014)
Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment? Science & Society series on Drugs and Science
David Nutt
EMBO REPORTS (2014)
Analysis and characterization of the novel psychoactive drug 4-chloromethcathinone (clephedrone)
Magdalena Taschwer et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
L. D. Simmler et al.
NEUROPHARMACOLOGY (2014)
Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats
Shawn M. Aarde et al.
ADDICTION BIOLOGY (2013)
Compartment Syndrome After Bath Salts Use: A Case Series
Michael Levine et al.
ANNALS OF EMERGENCY MEDICINE (2013)
Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone)
M. L. Miller et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports
Karen Miotto et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity
David M. Wood et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2013)
Presence and composition of cathinone derivatives in drug samples taken from a Drug Test Service in Spain (2010-2012)
Fernando Caudevilla-Galligo et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Analysis of Synthetic Cathinones Commonly Found in Bath Salts in Human Performance and Postmortem Toxicology: Method Development, Drug Distribution and Interpretation of Results
Laureen J. Marinetti et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2013)
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA
Mariana Angoa-Perez et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine
Narong Maneeton et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques
M. J. Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone
Raul Lopez-Arnau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
New Lethal highs'': A case of a deadly cocktail of GHB and Mephedrone
Mariarosaria Aromatario et al.
FORENSIC SCIENCE INTERNATIONAL (2012)
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects
Fernando Caudevilla-Galligo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Mephedrone: use, subjective effects and health risks
Adam Winstock et al.
ADDICTION (2011)
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats
J. Kehr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinones
Simon D. Brandt et al.
DRUG TESTING AND ANALYSIS (2011)
Instability of the ecstasy market and a new kid on the block: mephedrone
Tibor M. Brunt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
An analysis of the 'legal high' mephedrone
Simon Gibbons et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Analyses of second-generation 'legal highs' in the UK: Initial findings
Simon D. Brandt et al.
DRUG TESTING AND ANALYSIS (2010)
Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation
F. Ivy Carroll et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
Karen Hewett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Trends in the development of new antidepressants. Is there a light at the end of the tunnel?
P Pacher et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Novel aminopropiophenones as potential antidepressants
KF Foley et al.
DRUG DEVELOPMENT RESEARCH (2003)
Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs
KF Foley et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2002)
Share Paper
